Providence Hematology Logo

Heather Leitch, MD, PhD, FRCPC

Profile Information

Dr. Leitch completed a PhD in microbiology (leukemia stem cell research) at UBC in 1992. She graduated from medical school at UBC in 1995, trained in internal medicine at UBC, and completed a hematology fellowship at McGill University in 2000, where she also completed course requirements toward a master’s degree in epidemiology and biostatistics. She completed post-fellowship training with the Lymphoma Tumour Group at the B.C. Cancer Agency in 2002, and currently holds the position of Clinical Professor at UBC.

Dr. Leitch has been a member of the hematology/oncology group at St. Paul’s Hospital since 2004, and actively participates in research projects and clinical trials with a focus on hematological malignancies. Recent publications co-authored by Dr. Leitch have focused on the treatment of: iron overload in patients with myelodysplastic syndromes (MDS) and other acquired bone marrow failure syndromes; HIV-associated lymphoma; monoclonal B-cell lymphocytosis; and relapsed/refractory myeloma, MDS, and lymphoma. Dr. Leitch is a member of the UBC Department of Medicine Research Advisory and Equity Committees.

b2-440x240 Dr. Heather Leitch, Hematologist

Holds MD, PhD in microbiology, and FRCPC. Hematologist. Clinical Professor at UBC. Member of hemtology/oncology group at St. Paul’s Hospital.

Keeping ahead of COVID-19

As you are well aware, there is a global response to the COVID-19 epidemic and recently the Canadian Government has asked all of us to stay home, work remotely whenever possible, and make every effort to keep ourselves healthy as we strive to reduce the spread of the virus. Providence Hematology is committed to the health of our staff, our patients, and our communities and as such, we will be taking the necessary steps to keep everyone safe.